Relative ellipsoid zone reflectivity and its association with disease severity in age-related macular degeneration: a MACUSTAR study report

Author:

Saßmannshausen Marlene,Behning Charlotte,Isselmann Ben,Schmid Matthias,Finger Robert P.,Holz Frank G.,Schmitz-Valckenberg Steffen,Pfau Maximilian,Agostini H.,Altay L.,Atia R.,Bandello F.,Basile P. G.,Behning C.,Belmouhand M.,Berger M.,Binns A.,Boon C. J. F.,Böttger M.,Bouchet C.,Brazier J. E.,Butt T.,Carapezzi C.,Carlton J.,Carneiro A.,Charil A.,Coimbra R.,Cozzi M.,Crabb D. P.,Cunha-Vaz J.,Dahlke C.,de Sisternes L.,Dunbar H.,Finger R. P.,Fletcher E.,Floyd H.,Francisco C.,Gutfleisch M.,Hogg R.,Holz F. G.,Hoyng C. B.,Kilani A.,Krätzschmar J.,Kühlewein L.,Larsen M.,Leal S.,Lechanteur Y. T. E.,Luhmann U. F. O.,Lüning A.,Marques I.,Martinho C.,Montesano G.,Mulyukov Z.,Paques M.,Parodi B.,Parravano M.,Penas S.,Peters T.,Peto T.,Pfau M.,Poor S.,Priglinger S.,Rowen D.,Rubin G. S.,Sahel J.,Sánchez C.,Sander O.,Saßmannshausen M.,Schmid M.,Schmitz-Valckenberg S.,Schrinner-Fenske H.,Siedlecki J.,Silva R.,Skelly A.,Souied E.,Staurenghi G.,Stöhr L.,Taylor D. J.,Terheyden J. H.,Thiele S.,Tufail A.,Varano M.,Vieweg L.,Wintergerst L.,Wolf A.,Zakaria N.,Thiele Sarah,

Abstract

AbstractQuantification of the relative ellipsoid zone reflectivity (rEZR) might be a structural surrogate parameter for an early disease progression in the context of age-related macular degeneration (AMD). Within the European multicenter, cross-sectional MACUSTAR study, we have devised an automatic approach to determine the mean rEZR [arbitrary units, AU] at two independent visits in SD-OCT volume scans in study participants. Linear mixed-effects models were applied to analyze the association of AMD stage and AMD associated high-risk features including presence of pigmentary abnormalities, reticular pseudodrusen (RPD), volume of the retinal-pigment-epithelial–drusenoid-complex (RPEDC) with the rEZR. Intra-class correlation coefficients (ICC) were determined for rEZR reliability analysis. Within the overall study cohort (301 participants), we could observe decreased rEZR values (coefficient estimate ± standard error) of − 8.05 ± 2.44 AU (p = 0.0011) in the intermediate and of − 22.35 ± 3.28 AU (p < 0.0001) in the late AMD group. RPD presence was significantly associated with the rEZR in iAMD eyes (− 6.49 ± 3.14 AU; p = 0.0403), while there was a good ICC of 0.846 (95% confidence interval: 0.809; 0.876) in the overall study cohort. This study showed an association of rEZR with increasing disease severity and the presence of iAMD high-risk features. Further studies are necessary to evaluate the rEZR’s value as a novel biomarker for AMD and disease progression.

Funder

BONFOR GEROK Program, Faculty of Medicine, University of Bonn to MS.

Innovative Medicines Initiative 2 Joint Undertaking

BONFOR GEROK Program, Faculty of Medicine, University of Bonn to ST

German Research Foundation to ST

Rheinische Friedrich-Wilhelms-Universität Bonn

Publisher

Springer Science and Business Media LLC

Subject

Multidisciplinary

Reference46 articles.

1. Nashine, S. Potential therapeutic candidates for age-related macular degeneration (AMD). Cells 10(9), 2483. https://doi.org/10.3390/cells10092483 (2021).

2. Terluk, M. R. et al. Investigating mitochondria as a target for treating age-related macular degeneration. J. Neurosci. 35(18), 7304–7311. https://doi.org/10.1523/JNEUROSCI.0190-15.2015 (2015).

3. Allingham, M., Mettu, P. & Cousins, S. Elamipretide, a mitochondrial-targeted drug, for the treatment of vision loss in dry AMD with high risk drusen: Results of the Phase 1 ReCLAIM study. Investig. Ophthalmol. Vis. Sci., 974 (2018).

4. ReCLAIM-2 study to evaluate safety, efficacy and pharmacokinetics of elamipretide in subjects with AMD with non-central GA. https://clinicaltrials.gov/ct2/show/NCT03891875. Accessed July 20, 2021.

5. Ferris, F. L. et al. Clinical classification of age-related macular degeneration. Ophthalmology 120(4), 844–851. https://doi.org/10.1016/j.ophtha.2012.10.036 (2013).

Cited by 3 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3